Member Login
  1. Stocks
    2. /
  2. Hikma Pharmaceuticals PLC (LSE: HIK)
    3. /

LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

    Investing Articles

    2 FTSE 350 growth stocks I’d buy ASAP

    | G A Chester

    Now could be the perfect time to pick up shares in these two FTSE 350 (INDEXFTSE:NMX) growth companies.

    Read more »

    Investing Articles

    Are these bombed-out pharma stocks worth buying?

    | Rupert Hargreaves

    Should you catch these falling knives?

    Read more »

    Investing Articles

    2 ‘hot’ growth stocks I’d buy before it’s too late

    | Bilaal Mohamed

    Bilaal Mohamed explains why investors should consider these growth stocks before it's too late.

    Read more »

    Investing Articles

    Why I’d buy and hold Hikma Pharmaceuticals plc for the next decade

    | Peter Stephens

    Hikma Pharmaceuticals plc (LON: HIK) could be a stunning long-term growth stock.

    Read more »

    Investing Articles

    2 FTSE 100 growth stocks to buy before it’s too late?

    | Royston Wild

    Royston Wild discusses the investment potential of two FTSE 100 (INDEXFTSE: UKX) growth shares.

    Read more »

    Investing Articles

    These FTSE 100 stocks rocketed 20% in February. Can they keep going?

    | Royston Wild

    Royston Wild runs the rule over two FTSE 100 (INDEXFTSE: UKX) chargers.

    Read more »

    Investing Articles

    Why this growth stock could soar 40%+ within 2 years

    | Peter Stephens

    Stunning gains could be on the horizon for this company.

    Read more »

    Investing Articles

    A dividend stock and a growth stock I’d buy in February

    | Edward Sheldon, CFA

    Edward Sheldon identifies a dividend powerhouse and a growth stock that offer value at present.

    Read more »

    Investing Articles

    Kick-start 2017 with these explosive growth stocks

    | Bilaal Mohamed

    Bilaal Mohamed thinks these two pharmacetutical firms could be on the verge of spectacular gains in 2017.

    Read more »

    Investing Articles

    2 top healthcare shares for growth investors right now

    | Jack Tang

    Are these the best healthcare stocks to buy for 2017?

    Read more »

    Investing Articles

    2 defensive stocks looking attractive since recent falls

    | Kevin Godbold

    These defensive dividend growers are on sale.

    Read more »

    Investing Articles

    Could Vectura Group plc grow to be a FTSE 100 company within 10 years?

    | G A Chester

    Vectura Group plc (LON:VEC) could follow in the footsteps of Hikma Pharmaceuticals (LON:HIK), says G A Chester.

    Read more »